USD 0.28
(-3.45%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 13.97 Million | 20.95 Million | 34.52 Million | 13.09 Million |
Cost of Revenue | 12.75 Million | 15.2 Million | 28.69 Million | 8.57 Million |
Gross Profit | 1.21 Million | 5.75 Million | 5.83 Million | 4.52 Million |
Operating Expenses | 5.97 Million | 3.67 Million | 4.68 Million | 3.97 Million |
Selling, General and Administrative Expenses | 4.07 Million | 1.95 Million | 2.13 Million | 1.86 Million |
Research and Development Expenses | 1.89 Million | 1.46 Million | 2.33 Million | 1.87 Million |
Other Expenses | - | -136.39 Thousand | 47.09 Thousand | 121.75 Thousand |
Cost and Expenses | 18.73 Million | 18.88 Million | 33.37 Million | 12.54 Million |
Operating Income | -4.76 Million | 2.07 Million | 1.14 Million | 549.38 Thousand |
Interest Expense | 2.35 Million | 680.58 Thousand | 6568.00 | 2113.00 |
Income Tax Expense | 14.36 Thousand | 126.98 Thousand | 556.68 Thousand | -40.29 Thousand |
Earnings before Tax | -7.11 Million | 1.05 Million | 879.37 Thousand | 403.8 Thousand |
Net Income | -7.13 Million | 929.05 Thousand | 322.68 Thousand | 444.09 Thousand |
Earnings Per Share Basic | -0.33 | 0.04 | 0.01 | 0.02 |
Earnings Per Share Diluted | -0.35 | 0.04 | 0.01 | 0.02 |
Weighted Average Shares Outstanding | 21.38 Million | 23 Million | 23 Million | 23 Million |
Weighted Average Shares Outstanding (Diluted) | 20.27 Million | 23 Million | 23 Million | 23 Million |
Gross Margin | 0.09 | 0.27 | 0.17 | 0.35 |
EBIT Margin | -0.29 | 0.12 | 0.06 | 0.12 |
Profit Margin | -0.51 | 0.04 | 0.01 | 0.03 |
EBITDA | -4.08 Million | 2.67 Million | 1.96 Million | 1.41 Million |
Earnings Before Tax Margin | -0.34 | 0.10 | 0.03 | 0.04 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 3.88 Million | 4.59 Million | 13.97 Million | 4.53 Million | 2.16 Million | 4.54 Million |
Cost of Revenue | 2.98 Million | 3.05 Million | 12.75 Million | 4.21 Million | 3.42 Million | 3.63 Million |
Gross Profit | 900.62 Thousand | 1.54 Million | 1.21 Million | 324.69 Thousand | -1.26 Million | 902.76 Thousand |
Operating Expenses | 2.06 Million | 1.21 Million | 5.97 Million | 3.42 Million | 647.29 Thousand | 741.24 Thousand |
Selling, General and Administrative Expenses | 1.64 Million | 678.76 Thousand | - | 2.04 Million | 500.55 Thousand | 476.44 Thousand |
Research and Development Expenses | 419.58 Thousand | 512.59 Thousand | - | 1.28 Million | 99.16 Thousand | 210.1 Thousand |
Other Expenses | 250.24 Thousand | - | 1052.00 | 991.09 Thousand | -990.59 Thousand | 393.00 |
Cost and Expenses | 5.05 Million | 4.26 Million | 18.73 Million | 7.63 Million | 4.07 Million | 4.38 Million |
Operating Income | -1.16 Million | 327.98 Thousand | -4.76 Million | -3.41 Million | -1.91 Million | 161.51 Thousand |
Interest Expense | 77.69 Thousand | 267.94 Thousand | 2.35 Million | 1.27 Million | 20.68 Thousand | 853 Thousand |
Income Tax Expense | 2799.00 | 91.54 Thousand | 14.36 Thousand | 8597.00 | -969.9 Thousand | 389.00 |
Earnings before Tax | -994.69 Thousand | 60.03 Thousand | -7.11 Million | -3.69 Million | -2.92 Million | -696.69 Thousand |
Net Income | -997.49 Thousand | 60.03 Thousand | -7.13 Million | -3.69 Million | -2.92 Million | -697.08 Thousand |
Earnings Per Share Basic | -0.04 | 0.00 | - | -0.18 | -0.14 | -0.04 |
Earnings Per Share Diluted | -0.04 | 0.00 | - | -0.18 | -0.14 | -0.03 |
Weighted Average Shares Outstanding | 22.91 Million | 21.38 Million | 20.27 Million | 21.11 Million | 21.2 Million | 17.77 Million |
Weighted Average Shares Outstanding (Diluted) | 22.91 Million | 21.38 Million | 20.27 Million | 21.11 Million | 21.2 Million | 20 Million |
Gross Margin | 0.23 | 0.34 | 0.09 | 0.07 | -0.58 | 0.20 |
EBIT Margin | -0.29 | 0.10 | - | -0.48 | -1.25 | 0.04 |
Profit Margin | -0.26 | 0.01 | -0.51 | -0.82 | -1.35 | -0.15 |
EBITDA | -1.14 Million | 462.8 Thousand | - | -2.15 Million | -2.7 Million | 190.46 Thousand |
Earnings Before Tax Margin | -0.30 | 0.07 | -0.34 | -0.75 | -0.88 | 0.04 |
PCAR
300380
TOE
BETRF
AUROPHARMA
GSTC